Advertisement

The Indian Journal of Pediatrics

, Volume 86, Issue 9, pp 777–783 | Cite as

Prevalence and Risk Factors of Hypovitaminosis-D in Children with Cognitive and Movement Disorders

  • Anu Susan George
  • M. C. Mathew
  • Anna MathewEmail author
  • Susan Sosa Jacob
  • John Michael Raj
Original Article

Abstract

Objectives

To document the prevalence of hypovitaminosis-D in children with intellectual and movement disorders and to identify the risk factors in vitamin D deficient children.

Methods

This is a cross-sectional study on 90 children with neurodevelopmental disabilities. The prevalence of hypovitaminosis-D and the risk factors such as sun exposure, age-appropriate mobility, diet, skin color and anti-epileptic medications were examined in children with cognitive disorders and movement disorders.

Results

The mean serum vitamin D level in children with cognitive disability (n = 46) was found to be 26.7 ± 16.3 ng/L and in the children with movement disability (n = 44) it was 27.9 ± 10.5 ng/L. Though the risk factors were found in greater numbers in children in the deficient group (vitamin D < 30 ng/L), the difference between the two groups was not significant. Of the 90 children, 86 (95.5%) had at least one sign of vitamin D deficiency. Lowest levels of vitamin D were seen in autistic spectrum disorder and learning disabilities in the Cognitive Disability group and hemiplegia in the Movement Disability group.

Conclusions

The prevalence of vitamin D deficiency in children with neurodevelopmental disabilities was 72.2%, with 76.1% in the cognitive disability group and 68.2% in the movement disability group. The risk factors were more common in vitamin D deficient children.

Keywords

Hypovitaminosis-D Neuromuscular disability Cognitive disability Movement disability Vitamin D deficient Calcidiol 

Notes

Acknowledgements

The authors are grateful to the Short Term Studentship (STS) programme of the ICMR for giving medical students the opportunity to do a research project. They acknowledge the Dean, Management, Faculty and staff of Developmental Pediatrics and Child Neurology and the Research department of this institution for enabling this research study to be conducted.

Authors’ Contribution

ASG: Principal investigator, conducted the study and collected the data; MCM: Supervised clinical data collection and clinical aspects of the study; AM: Guide - oversaw the research methodology, helped in writing the protocol and report; SSJ: Helped in data collection and participant interviewing; JMR: Biostatistical analysis. AM is the guarantor for this paper.

Compliance with Ethical Standards

Conflict of Interest

None.

Source of Funding

This study was approved by the Short term studentship programme of the ICMR and the student received a grant from the ICMR.

References

  1. 1.
    Zadshir A, Tareen N, Pan D, Norris KC, Martins D. The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis. 2005;15:S5–97-101.Google Scholar
  2. 2.
    Norris JM. Can the sunshine vitamin shed light on type 1 diabetes? Lancet. 2001;358:1476–8.CrossRefGoogle Scholar
  3. 3.
    Rajakumar K, Greenspan SL, Thomas SB, Holick MF. Solar ultraviolet radiation and vitamin D: a historical perspective. Am J Public Health. 2007;97:1746–54.CrossRefGoogle Scholar
  4. 4.
    Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006;116:2062–72.CrossRefGoogle Scholar
  5. 5.
    Grant WB, Wimalawansa SJ, Holick MF, et al. Emphasizing the health benefits of vitamin D for those with neurodevelopmental disorders and intellectual disabilities. Nutrients. 2015;7:1538–64.CrossRefGoogle Scholar
  6. 6.
    Vasudevan J, Gopireddy MMR, Anthony J, Thayumanavam S, Devi U, Rathinasamy M. Prevalence and factors associated with vitamin D deficiency in Indian children: a hospital based cross-sectional study. Pediatr Oncall J. 2014;12:71–6.Google Scholar
  7. 7.
    Nicolaidou P, Georgouli H, Kotsalis H, et al. Effects of anticonvulsant therapy on vitamin D status in children: prospective monitoring study. J Child Neurol. 2006;21:205–9.Google Scholar
  8. 8.
    Bener A, Khattab AO, Al-Dabbagh MM. Is high prevalence of vitamin D deficiency evidence for autism disorder?: in a highly endogamous population. J Pediatr Neurosci. 2014;9:227–33.CrossRefGoogle Scholar
  9. 9.
    Frighi V, Morovat A, Stephenson MT, White SJ, Hammond CV, Goodwin GM. Vitamin D deficiency in patients with intellectual disabilities: prevalence, risk factors and management. Br J Psychiatry. 2014;205:458–64.CrossRefGoogle Scholar
  10. 10.
    Kilpinen-Loisa P, Nenonen H, Pihko H, Mäkitie O. High-dose vitamin D supplementation in children with cerebral palsy or neuromuscular disorder. Neuropediatrics. 2007;38:167–72.CrossRefGoogle Scholar
  11. 11.
    Pettifor JM. Vitamin D &/or calcium deficiency rickets in infants & children: a global perspective. Indian J Med Res. 2008;127:245–9.Google Scholar
  12. 12.
    Sample size measured using nMaster2.0 Sample Size Calculation software. Tamil Nadu, India: Department of Biostatistics, Christian Medical College; August 2011.Google Scholar
  13. 13.
    Maheshwaran G. Kuppuswamy's socio-economic status scale – a revision of income parameter for 2014. Int J Recent Trends Sci Technol. 2014;11:01–2.CrossRefGoogle Scholar
  14. 14.
    Holick MF. Vitamin D status: measurement, interpretation and clinical application. Ann Epidemiol. 2009;19:73–8.CrossRefGoogle Scholar
  15. 15.
    Greenway A, Zacharin M. Vitamin D status of chronically ill or disabled children in Victoria. J Paediatr Child Health. 2003;39:543–7.CrossRefGoogle Scholar
  16. 16.
    Cheema MA, Lone KP, Razi F. Quantitative ultrasound bone profile and vitamin D status in 5-11 years old children with intellectual disability. J Pak Med Assoc. 2016;66:694–8.Google Scholar
  17. 17.
    Kocovska E, Fernell E, Billstedt E, Minnis H, Gillberg C. Vitamin D and autism: clinical review. Res Dev Disabil. 2012;33:1541–50.CrossRefGoogle Scholar
  18. 18.
    Wimalawansa SJ. Vitamin D adequacy and improvements of comorbidities in persons with intellectual developmental disabilities. J Child Dev Disord. 2016;2(3).Google Scholar
  19. 19.
    Brandi ML, Minisola S. Calcidiol [25(OH)D3]: from diagnostic marker to therapeutic agent. Curr Med Res Opin. 2013;29:1565–72.CrossRefGoogle Scholar
  20. 20.
    The South Australian Paediatric Clinical Guidelines Reference Committee. Vitamin D Deficiency in Children. The South Australian Paediatric Clinical Guidelines 24 January 2012. Available at: cywhs.paediatricclinicalguidelines@health.sa.gov.au. Accessed in July 2017.Google Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2019

Authors and Affiliations

  1. 1.MOSC Medical CollegeKolencheryIndia
  2. 2.Department of Developmental Pediatrics and Child NeurologyMOSC Medical CollegeKolencheryIndia
  3. 3.Department of PharmacologyMOSC Medical CollegeErnakulamIndia
  4. 4.Department of BiostatisticsSt. John’s Medical CollegeBangaluruIndia

Personalised recommendations